SCHEMBL17417969

SCHEMBL17417969

COC(=O)c1cccc(B2OC(C)(C)C(C)(C)O2)c1OCCc1cc(C)cc(OC)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ UCHL1 P09936 1/20 0.37
▸ ALDH1A1 P00352 3/20 0.36
▸ MAPT P10636 3/20 0.36
▸ HTT P42858 2/20 0.36
▸ KDM4E B2RXH2 2/20 0.36
▸ HPGD P15428 1/20 0.36
▸ HSP90AA1 P07900 1/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.34
▸ PPARG P37231 4/20 0.34
▸ PPARA Q07869 3/20 0.34
▸ SIRT2 Q8IXJ6 2/20 0.33
▸ MAOB P27338 1/20 0.33
▸ TP53 P04637 1/20 0.32
▸ THRB P10828 1/20 0.32
▸ POLB P06746 1/20 0.32
▸ GAA P10253 1/20 0.32
▸ LIPE Q05469 1/20 0.32
▸ VDR P11473 1/20 0.32
▸ HIF1A Q16665 1/20 0.32
▸ TSHR P16473 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17385847 0.83 UCHL1 (0.34) UCHL1MAPTHTTKDM4EHPGD
SCHEMBL17386122 0.80 UCHL1 (0.39) UCHL1ALDH1A1MAPTTSHR
SCHEMBL17385786 0.80 MAPT (0.38) ALDH1A1MAPTHTTKDM4EHPGD
SCHEMBL25245488 0.77 TSHR (0.39) UCHL1ALDH1A1MAPTHTTKDM4E
SCHEMBL17429667 0.76 LIPG (0.35) ALDH1A1MAPTNPSR1GAAHSD17B10
SCHEMBL17418052 0.73 UCHL1 (0.40) UCHL1ALDH1A1MAPTVDR
SCHEMBL17429672 0.72 UCHL1 (0.36) UCHL1ALDH1A1MAPTKDM4E
SCHEMBL562324 0.71 LMNA (0.40) UCHL1ALDH1A1KDM4EPOLBTSHR
SCHEMBL16237751 0.70 UCHL1 (0.48) UCHL1ALDH1A1MAPTHTTKDM4E
SCHEMBL9986523 0.69 LMNA (0.47) ALDH1A1MAPTHTTKDM4EPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9643946-B2 Tricyclic compound and use thereof SK CHEMICALS CO., LTD. (KR) 2017-05-09 — — US disclosed
US-9643946-B2 Tricyclic compound and use thereof SK CHEMICALS CO., LTD. (KR) 2017-05-09 — — US disclosed
US-20160009677-A1 TRICYCLIC COMPOUND AND USE THEREOF SK CHEMICALS CO., LTD. (KR) 2016-01-14 — — US disclosed
US-20160009677-A1 TRICYCLIC COMPOUND AND USE THEREOF SK CHEMICALS CO., LTD. (KR) 2016-01-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160009677-A1 TRICYCLIC COMPOUND AND USE THEREOF GPR65, GPR119, GPR35 UCHL1 4494/4885ALDH1A1 2066/4885MAPT 2131/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback